CorMedix
CRMD
10,08 €
Share price
-2.84%
Change (1 day)
132.86%
Change (1 year)
Categories
Revenue for CorMedix (CRMD)
Revenue in 2025 (TTM): €77.15 Million
According to CorMedix's latest financial reports the company's current revenue (TTM 
) is €71.45 Million. In 2024 the company made a revenue of €41.77 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CorMedix from 2009 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | €77.15 M | 84.69% |
| 2024 | €41.77 M | |
| 2023 | N/A | -100% |
| 2022 | €0.06 M | -63.83% |
| 2021 | €0.16 M | -13.32% |
| 2020 | €0.19 M | -23.08% |
| 2019 | €0.25 M | -32.7% |
| 2018 | €0.37 M | 36.88% |
| 2017 | €0.27 M | 28.83% |
| 2016 | €0.21 M | 10.86% |
| 2015 | €0.19 M | 23.49% |
| 2014 | €0.15 M | 10640.7% |
| 2013 | €0 M | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | €18.06 B | 25,176.84% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | €0.80 B | 1,026.90% | 🇺🇸 USA |
 Utah Medical Products UTMD | €33.99 M | -52.43% | 🇺🇸 USA |